Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hiroyuki Masuda is active.

Publication


Featured researches published by Hiroyuki Masuda.


World Journal of Surgery | 1988

Epidermal growth factor receptor on human thyroid neoplasms.

Hiroyuki Masuda; Akira Sugenoya; Shinya Kobayashi; Yoshio Kasuga; Futoshi Iida

AbstractMorphological observation of epidermal growth factor receptor (EGF-R) was attempted for human thyroid neoplasms, and the results were evaluated compared with the various histological types. Thirty-four malignant tumors, 24 benign tumors, 7 adenomatous goiters, and 7 normal thyroid tissues obtained at surgery were subjected to this study. They were fixed in 10% formalin solution, embedded in paraffin. After sectioning at 4μm, immunohistochemical staining by avidin-biotin-peroxidase complex technique was performed employing anti-human EGF-R monoclonal antibody. Both normal thyroid tissues and benign adenomas showed no apparent immunoreactive staining. The majority of the malignant tumors, however, demonstrated dark brown reaction products indicating location of EGF-R on the cell surface, cytoplasm, and nuclear envelope. Medullary and anaplastic carcinomas were stained more intensively than papillary and follicular carcinomas. In adenomatous goiter, the immunoreactive products were occasionally observed on the follicular cells of some limited areas, whereas its staining pattern was different from the malignant neoplasms. The correlative study between UICC classification of thyroid tumors and EGF-R staining in the papillary carcinoma revealed a higher frequency of positive staining in cases of multifocal metastasis.RésuméDans cette étude, on a mis en évidence le récepteur du facteur de croissance épithélial (R-FCE) dans les tumeurs de la thyroïde. Les caratéristiques immunohistologiques ont été étudiés dans les différentes variétés histologiques.On a donc étudié 34 tumeurs malignes, 24 tumeurs bénignes, 7 goitres adénomateux, et 7 pièces comportant du tissu normal, prélevés lors de la chirurgie de la thyroïde. Tous les tissus ont été fixés au formol à 10% et inclus dans de la paraffine. Après des coupes de 4μm, on a effectué une coloration immunohistochimique par la technique du complexe avidine-biotineperoxydase en utilisant des anticorps R-FCE humains monoclonaux.La coloration des tissus normaux et des adénomes bénins était apparemment immunonégative. La plupart des tumeurs malignes cependant ont montré des substances marron foncé, indiquant la présence de R-FCE sur la surface cellulaire, dans le cytoplasme et sur la membrane du noyau. Les cancers anaplasiques et médullaires ont présenté une coloration plus intense que celle des cancers papillaires et folliculaires. Dans le goitre adénomateux, on a mis en évidence, par endoit, des substances immuno-réactives dans quelques cellules folliculaires, mais les résultats de coloration différait de ceux obtenus dans les tumeurs malignes.Une étude de corrélation entre la classification UICC des tumeurs thyroïdiennes et la coloration R-FCE des cancers papillaires, a démontré une fréquence accrue de coloration positive en cas de métastases multifocales.ResumenEl factor de crecimiento epidermal (FCE) es un subgrupo de diversos polipéptidos de crecimiento involucrados en la regulación del crecimiento y diferenciación celulares. El FCE se liga a receptores específicos (FCE-R) de la membrana celular de sus órganos blanco (target organs); es considerado como un oncogen por su homología con el oncogen transformador v-erb B del virus de la eritroblastosis de las aves. Se ha demostrado la presencia de FCE-R en algunos tumores del esófago, estómago, seno, vejiga, pulmón, cerebro, ovario, y útero. La identificación del FCE-R es esencial en la yaloración del comportamiento biológico de los tumores sólidos. Este trabajo demuestra la reactividad de un anticuerpo monoclonal anti FCE-R con células de neoplasmas tiroideas así como la ubicación de FCE-R.El estudio tuvo como propósito la observación morfológica de FCE-R en neoplasmas tiroideos y su comparación con los diversos tipos histológicos.Treinta y cuatro tumores malignos, 24 tumores benignos, 7 bocios adenomatosos, y 7 tejidos normales obtenidos durante la cirugía fueron sometidos a estudio. Los especímenes fueron fijados en solutión de formol al 10% incluídos en parafina. Una vez seccionados a un espesor de 4μm, se realizó la coloración inmunohistoquímica con la técnica del complejo de avidinabiotina-peroxidasa empleando un anticuerpo monoclonal murino contra FCE-R humano.Tanto los tejidos tiroideos normales como los adenomas benignos exhibieron ausencia de coloración inmunorreactiva. Sin embargo, la mayoría de los tumores malignos demostraron la presencia de productos con una reacción marrón oscura indicativa de la ubicación de FCE-R en la superficie celular, el citoplasma, y la envoltura nuclear. Los carcinomas medulares y anaplásicos aparecieron con coloraciones más intensas que los carcinomas papilares y foliculares. En el bocio adenomatoso los productos inmunorreactivos fueron ocasionalmente observados en las células foliculares de áreas limitadas, al tiempo que su patrón de coloración fue diferente del de los neoplasmas malignos.El estudio correlativo entre la clasificación de la UICC (Union International Contra el Cáncer) de los tumores tiroideos y la coloración de FCE-R en el carcinoma papilar demostró una mayor frecuencia de coloración positiva en casos con metastasis multifocales.De los resultados del estudio se puede concluír que: (a) el carcinoma tiroideo puede poseer mayor cantidad de FCE-R y mayor afinidad de ligazón que el tumor benigno, (b) la presencia de FCE-R puede correlacionarse con los diversos grados de malignidad en el carcinoma tiroideo, (c) el bocio adenomatoso puede poseer algún potencial de malignidad.


Surgery Today | 1988

An evaluation of the intraoperative staining technique using methylene blue for the detection of hyperplastic parathyroid glands

Shinya Kobayashi; Makoto Miyakawa; Akira Sugenoya; Osamu Senga; Gengo Kaneko; Tamotsu Yokozawa; Yoshio Kasuga; Hiroyuki Masuda; Yu Tai Chang; Futoshi Iida

Intraoperative staining with methylene blue was employed during parathyroid surgery on 50 glands from 13 patients, 5 with primary and 8 with secondary hyperparathyroidism. Forty-seven out of the 50 glands (94 per cent) were visualized by the staining and 2 out of the 13 patients were revealed to have supernumerary parathyroid glands. Since we started using this technique, there have been no cases of persistent hypercalcemia. The results of this study support the clinical usefulness of this staining procedure for detecting hyperplastic parathyroid glands in both primary and secondary hyperparathyroidism.


Clinical Endocrinology | 1993

A case of papillary carcinoma of the thyroid with more than 30 years long-term asymptomatic pulmonary metastases

Masayuki Maruyama; Akira Sugenoya; Shinya Kobayashi; Hiroyuki Masuda; Tadahiro Shimizu; Futoshi Lida

This is a case report of a patient with thyroid cancer with asymptomatic pulmonary metastases, and without obvious progression over 34 years.


Surgery Today | 1991

The problems encountered in the surgical management of primary hyperparathyroidism

Shinya Kobayashi; Akira Sugenoya; Yoshio Kasuga; Hiroyuki Masuda; Minoru Fujimori; Makoto Komatsu; Shouzou Takahashi; Tadahiro Shimizu; Shirou Yokoyama; Futoshi Iida; Makoto Miyakawa

The problems encountered in the diagnosis and treatment of primary hyperparathyroidism were studied in 69 cases. The accuracy of imaging for hyperplasia was less than that for adenoma or carcinoma and the major causes for multiple operations were a failure to locate the four glands and mediastinal adenoma. The intravenous administration of high doses of calcitonin could reduce the serum calcium level of patients in hypercalcemic crisis. Carcinoma required ipsilateral modified radical neck dissection because of lymph node metastases, and non-medullary thyroid carcinoma was often associated with primary hyperparathyroidism. We found removal of the parathyroid adenoma and biopsy or extirpation of only one macroscopically normal gland to be a fully satisfactory procedure after bilateral neck exploration and attempting to identify at least four glands.


Surgery Today | 1993

The outcome of patients with thyroid carcinoma and graves' disease

Yoshio Kasuga; Akira Sugenoya; Shinya Kobayashi; Hiroyuki Masuda; Futoshi Iida


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 1993

Surgical strategies for differentiated carcinoma of the thyroid isthmus.

Akira Sugenoya; Kiyoshi Shingu; Shinya Kobayashi; Hiroyuki Masuda; Shozo Takahashi; Tadahiro Shimizu; Hiroshi Onuma; Kazuhiko Asanuma; Nobuo Ito; Futoshi Iida


Thyroid | 1995

Thyroid Abnormalities among Children in the Contaminated Area Related to the Chernobyl Accident

Akira Sugenoya; Kazuhiko Asanuma; Yoshihisa Hama; Hiroyuki Masuda; Gennadij S. Skidanenko; Altusina Tatiana Anatoliebna; Kenichi Koike; Atsushi Komiyama; Futoshi Iida


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 1995

Management of tracheal wall resection for thyroid carcinoma by tracheocutaneous fenestration and delayed closure using auricular cartilage

Akira Sugenoya; Kiyoshi Matsuo; Kazuhiko Asanuma; Kiyoshi Shingu; Tadahiro Shimizu; Hiroyuki Masuda; Shinya Kobayashi; Futoshi Iida


British Journal of Surgery | 1992

Adenomatous goitre: Therapeutic strategy, postoperative outcome, and study of epidermal growth factor receptor

Akira Sugenoya; Hiroyuki Masuda; Makoto Komatsu; Shirou Yokoyama; Tadahiro Shimizu; Minoru Fujimori; Shinya Kobayashi; Futoshi Iida


European Journal of Endocrinology | 1991

ANTI-TRIIODOTHYRONINE AUTOANTIBODIES IN A EUTHYROID WOMAN : CONFIRMATION OF IMMUNOGLOBULIN G ANTIBODIES EMPLOYING PROTEIN A COLUMN CHROMATOGRAPHY

Akira Sugenoya; Emiko Mizuno; Masayuki Haniuda; Minoru Fujimori; Hiroyuki Masuda; Yoshio Kasuga; Shinya Kobayashi; Futoshi Iida

Collaboration


Dive into the Hiroyuki Masuda's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge